CTI BIOPHARMA CORP's ticker is and the CUSIP is 12648L956. A total of 4 filers reported holding CTI BIOPHARMA CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $7,000 | -41.7% | 6,000 | -26.8% | 0.00% | – |
| Q3 2015 | $12,000 | 0.0% | 8,200 | +36.7% | 0.00% | – |
| Q2 2015 | $12,000 | -95.2% | 6,000 | -95.6% | 0.00% | -100.0% |
| Q1 2015 | $248,000 | +300.0% | 137,000 | +422.9% | 0.00% | +300.0% |
| Q4 2014 | $62,000 | +520.0% | 26,200 | +539.0% | 0.00% | – |
| Q3 2014 | $10,000 | -89.4% | 4,100 | -87.7% | 0.00% | -100.0% |
| Q2 2014 | $94,000 | – | 33,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 256 | $60,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 26,200 | $62,000 | 0.00% |
| Citadel Advisors | 30,800 | $73,000 | 0.00% |
| SIMPLEX TRADING, LLC | 7 | $1,000 | 0.00% |